Bourla comments add to cloud over Prasad

Pressure continues to mount on Vinay Prasad in the wake of FDA’s U-turn on a Moderna vaccine with Albert Bourla becoming one of the first CEOs of a major company to publicly call out the director of the Center for Biologics Evaluation and Research.

“We have a problem with the leadership of CBER,” the chairman and CEO of Pfizer Inc. (NYSE:PFE) said on Monday while speaking at the TD Cowen Healthcare Conference. “I think the current director is not following the recommendations of his staff.”...